Surgepays is trading at $0.16 (-5.95%) as U.S. futures weakened amid rate, oil, and geopolitical concerns.

  • No new company-specific announcement was identified for September 14, 2026.
  • On September 10, Surgepays sold three business lines for $27.5 million in GPO Plus preferred stock, supporting the prior session’s gain but not directly explaining today’s decline.
  • The broader market backdrop likely contributed to pre-market pressure.